Quantification of inflammatory activity in patients with Crohn's disease using diffusion weighted imaging (DWI) in MR

Nora Stanescu-Siegmund1, Yessica Nimsch1, Arthur P Wunderlich1

  • 11 Department of Diagnostic and Interventional Radiology, University Hospital of Ulm, Ulm, Germany.

Insights

Diffusion-weighted MRI (DWI-MRI) effectively identifies inflamed bowel segments in Crohn's disease patients. Apparent diffusion coefficients (ADC) correlate strongly with disease severity (HBI), with a specific threshold distinguishing inflamed from normal tissue.

Area of Science:

  • Gastroenterology
  • Radiology
  • Medical Imaging

Background:

  • Diffusion-weighted magnetic resonance imaging (DWI-MRI) shows promise for detecting inflamed bowel segments.
  • Previous studies were limited by small patient cohorts and primarily used MR enterography.
  • Crohn's disease diagnosis and monitoring require accurate assessment of bowel inflammation.

Purpose of the Study:

  • To assess the feasibility of using DWI in MR enteroclysis and MR enterography for detecting inflamed bowel segments in a large Crohn's disease patient cohort.
  • To compare the efficacy of MR enteroclysis and MR enterography with DWI.
  • To correlate imaging findings with clinical parameters, specifically the Harvey-Bradshaw Index (HBI).

Main Methods:

  • 96 patients underwent MRI enteroclysis with DWI; 35 patients underwent MR enterography with DWI.
  • Apparent diffusion coefficients (ADC) were measured in inflamed and normal bowel segments.
  • Harvey-Bradshaw Index (HBI) scores were recorded; 208 bowel segments were analyzed.

Main Results:

  • Inflamed bowel segments exhibited significantly lower ADC values compared to normal segments (P < 0.001).
  • An ADC threshold of 1.56 × 10⁻³ mm²/s achieved 97.4% sensitivity and 99.2% specificity in differentiating inflamed from normal bowel.
  • No significant differences in ADC values were observed between MR enteroclysis and MR enterography (P = 0.383 for inflammation, P = 0.223 for normal wall).

Conclusions:

  • DWI-MRI is a feasible technique for identifying inflamed bowel segments in Crohn's disease patients.
  • ADC values demonstrate an excellent correlation with the Harvey-Bradshaw Index (P = 0.001), reflecting disease activity.
  • MR enteroclysis and MR enterography with DWI yield comparable results for assessing bowel inflammation.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
584
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
717
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K